Benign neoplasm of retina

Summary

Benign neoplasm of retina (MONDO:0021453) is a cancer. A subtype of retina neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	benign neoplasm of retina
Mondo ID	MONDO:0021453
ICD-10-CM	D31.2
ICD-11	1433648317
NCIT	C3624
SNOMED CT	92321003
UMLS	C0154027
MedGen	57580
Anatomy (UBERON)	UBERON:0000966
Is cancer (heuristic)	yes

Also known as: benign neoplasm of the retina · benign retina neoplasm · benign retina tumor · benign retina tumour · benign retinal neoplasm · benign retinal tumor · benign retinal tumour · benign tumor of retina · benign tumor of the retina · benign tumour of retina · benign tumour of the retina · retina benign neoplasm

Disease family

This is a subtype of retina neoplasm. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › nervous system disorder › retinal disorder › retina neoplasm › benign neoplasm of retina

Related subtypes (4): retinal cancer, retinal capillary malformation, retinal neuroblastoma, retinal cell neoplasm

Subtypes (2): vasoproliferative tumor of retina, hemangioma of retina

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.